| 000 | 01755 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513141648.0 | ||
| 264 | 0 | _c19980429 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s002800050773 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHerbst, R S | |
| 245 | 0 | 0 |
_aPaclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1998 |
||
| 300 |
_a497-504 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Marrow Cells _xdrug effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Lewis Lung _xblood supply |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aColony-Forming Units Assay |
| 650 | 0 | 4 | _aCyclohexanes |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xblood supply |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMinocycline _xadministration & dosage |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 | _aO-(Chloroacetylcarbamoyl)fumagillol |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aSesquiterpenes _xadministration & dosage |
| 700 | 1 | _aTakeuchi, H | |
| 700 | 1 | _aTeicher, B A | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 41 _gno. 6 _gp. 497-504 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002800050773 _zAvailable from publisher's website |
| 999 |
_c9521788 _d9521788 |
||